• Home
  • Stocks
  • Global Longlife Hospital and Research Ltd.

Global Longlife Hospital and Research Ltd.

View in App
44.30 +3.35 ▲8.2%

02 May 2024, 02:26:00 PM
Volume: 25,000

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Industry Icon Hospital & Healthcare Services Compare with Industry peers
Website http://www.globalhospital.co.in
Market Cap 43.00 Cr.
Enterprise Value(EV) 54.30 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 1.74 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 23.53 Trailing Twelve Months Ending 2023-03
Industry PE 66.47 Trailing Twelve Months Ending 2023-03
Book Value / Share 58.94 Trailing Twelve Months Ending 2023-03
Price to Book Value 0.69 Calculated using Price: 40.95
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 1.05 Cr. 10,500,000 Shares
FaceValue 10
About Global Longlife Hospital and Research Ltd.
The company provides health care services. The company offers Oncology, Ophthalmology, Cardiology, Dermatology, Gynecology, Spine Surgery, Plastic Surgery, Ultrasound, Microbiology, Dialysis, and Physiotherapy among other healthcare services. Global Longlife Hospital is certified by the National Accreditation Board for Hospitals and Healthcare Providers (NABH Accredited).

Global Longlife Hospital and Research Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Global Longlife Hospital and Research Ltd. Performance

View details >>
1 Day
+8.18%
1 Week
+3.80%
1 Month
+13.44%
3 Month
-18.60%
6 Month
+10.75%
1 Year
+0.54%
2 Year
5 Year
10 Year

Global Longlife Hospital and Research Ltd. Fundamental Ratios

View details >>
5 years 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 11.05 -7.23 18.94 29.65 4.82
Return on Capital Employed (%) 12.09 3.69 13.49 29.36 6.69
Return on Assets (%) 3.4 -2.19 5.72 11.1 3.47

Global Longlife Hospital and Research Ltd. Balance Sheet

View details >>
Particulars 6 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 12 11 14 17 64 65
Non Curr. Liab. 15 14 9 1 2 0
Curr. Liab. 13 13 10 14 8 12
Minority Int.
Equity & Liab. 40 39 33 31 74 77
Non Curr. Assets 25 23 18 17 38 40
Curr. Assets 15 16 12 11 34 37
Misc. Exp. not W/O 4 3 2
Total Assets 40 39 33 31 74 77

Global Longlife Hospital and Research Ltd. Profit and Loss

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Net Sales 35 34 33 33 24
Other Income 0 0 0 0 0
Total Income 35 34 33 33 24
Total Expenditure -28 -30 -27 -25 -19
PBIDT 7 4 6 8 4
Interest -2 -2 -2 -2 0
Depreciation -2 -2 -1 -1 -1
Taxation -1 0 0 -2 -1
Exceptional Items
PAT 1 -1 2 4 2
Adjusted EPS 3 5 2

Global Longlife Hospital and Research Ltd. Cash Flow

View details >>
Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 5 4 7 9 -40
Cash Fr. Inv. 0 0 0 0 -2
Cash Fr. Finan. -5 -3 -7 -10 46
Net Change 0 1 0 0 3
Cash & Cash Eqvt 0 1 0 0 4

Global Longlife Hospital and Research Ltd. Shareholding Pattern

View details >>
8 Qtrs 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 54.29 54.29 54.29 54.29 54.29 54.29 54.29 54.29
Public 45.71 45.71 45.71 45.71 45.71 45.71 45.71 45.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
No. of Shareholders (in Lacs)

Global Longlife Hospital and Research Ltd. Announcements

View details >>
Mon, 29 Apr 2024
Submission Of Certificate Under Regulation 40(9) Read With Regulation 40(10) Of The SEBI (LODR) Regulations 2015
Certificate under Regulation 40(9) read with Regulation 40(10) of the SEBI (LODR) Regulations 2015
Fri, 19 Apr 2024
Compliance Certificate For The Year Ended 31.03.2024 As Required Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Submission of Compliance Certificate for the year ended 31.03.2024
Fri, 19 Apr 2024
Notice Of EGM To Be Held On Tuesday 14Th May 2024
Notice of EGM to be held on Tuesday 14th May 2024

Global Longlife Hospital and Research Ltd. Technical Scans

View details >>
Tue, 30 Apr 2024
High Delivery Percentage High Delivery Percentage
Opening at High Opening at High
Opening at Low Opening at Low
Closing Above Previous High Closing Above Previous High
Close Within 52 Week Low Zone Close Within 52 Week Low Zone

Global Longlife Hospital and Research Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,874.59 1,521.10 +1.3%
Cipla Ltd. 114,557.24 1,419.50 +1.4%
Divi's Laboratories Ltd. 104,804.34 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. 104,403.21 6,262.55 +0.9%
Zydus Lifesciences Ltd. 99,214.67 982.90 +3.1%
Mankind Pharma Ltd. 94,488.80 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. 90,090.79 2,674.95 +1.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.08 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-12 30.89 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-12 75.78 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 19.97 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 33.36 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-12 54.71 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.30 2,674.95 +1.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.86 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-12 4.42 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-12 8.04 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.88 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-12 5.26 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-12 10.64 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.60 2,674.95 +1.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,674.95 +1.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,674.95 +1.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,674.95 +1.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,674.95 +1.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,521.10 +1.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,419.50 +1.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,978.75 -0.6%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,262.55 +0.9%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 982.90 +3.1%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,339.00 -1.1%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,674.95 +1.2%

Global Longlife Hospital and Research Ltd. FAQ's

What is Global Longlife Hosp share price?
Can I buy Global Longlife Hosp shares now?
What is the Market Cap of Global Longlife Hosp?
What are the key metrics to analyse Global Longlife Hosp?
What is the 52 Week High and Low of Global Longlife Hosp?
What is the trend of Global Longlife Hosp share price?